NCT01915498 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 8
- group Id
- BG004
- value
- 5
- group Id
- BG005
- value
- 9
- group Id
- BG006
- value
- 7
- group Id
- BG007
- value
- 22
- group Id
- BG008
- value
- 6
- group Id
- BG009
- value
- 14
- group Id
- BG010
- value
- 9
- group Id
- BG011
- value
- 5
- units
- Participants
- groups
- description
- Participants received enasidenib 30 mg tablets twice a day (BID) on Day 1 to Day 28 of each 28-day treatment cycle until disease progression or development of unacceptable toxicity.
- id
- BG000
- title
- Phase 1 Dose Escalation: Enasidenib 30 mg BID
- description
- Participants received enasidenib 50 mg tablets BID on Day 1 to Day 28 of each 28-day treatment cycle until disease progression or development of unacceptable toxicity.
- id
- BG001
- title
- Phase 1 Dose Escalation: Enasidenib 50 mg BID
- description
- Participants received enasidenib 75 mg tablets BID on Day 1 to Day 28 of each 28-day treatment cycle until disease progression or development of unacceptable toxicity.
- id
- BG002
- title
- Phase 1 Dose Escalation: Enasidenib 75 mg BID
- description
- Participants received enasidenib 100 mg tablets BID on Day 1 to Day 28 of each 28-day treatment cycle until disease progression or development of unacceptable toxicity.
- id
- BG003
- title
- Phase 1 Dose Escalation: Enasidenib 100 mg BID
- description
- Participants received enasidenib 150 mg tablets BID on Day 1 to Day 28 of each 28-day treatment cycle until disease progression or development of unacceptable toxicity.
- id
- BG004
- title
- Phase 1 Dose Escalation: Enasidenib 150 mg BID
- description
- Participants received enasidenib 50 mg tablets once a day (QD) on Day 1 to Day 28 of each 28-day treatment cycle until disease progression or development of unacceptable toxicity.
- id
- BG005
- title
- Phase 1 Dose Escalation: Enasidenib 50 mg QD
- description
- Participants received enasidenib 75 mg tablets QD on Day 1 to Day 28 of each 28-day treatment cycle until disease progression or development of unacceptable toxicity.
- id
- BG006
- title
- Phase 1 Dose Escalation: Enasidenib 75 mg QD
- description
- Participants received enasidenib 100 mg tablets QD on Day 1 to Day 28 of each 28-day treatment cycle until disease progression or development of unacceptable toxicity.
- id
- BG007
- title
- Phase 1 Dose Escalation: Enasidenib 100 mg QD
- description
- Participants received enasidenib 150 mg tablets QD on Day 1 to Day 28 of each 28-day treatment cycle until disease progression or development of unacceptable toxicity.
- id
- BG008
- title
- Phase 1 Dose Escalation: Enasidenib 150 mg QD
- description
- Participants received enasidenib 200 mg tablets QD on Day 1 to Day 28 of each 28-day treatment cycle until disease progression or development of unacceptable toxicity.
- id
- BG009
- title
- Phase 1 Dose Escalation: Enasidenib 200 mg QD
- description
- Participants received enasidenib 300 mg tablets QD on Day 1 to Day 28 of each 28-day treatment cycle until disease progression or development of unacceptable toxicity.
- id
- BG010
- title
- Phase 1 Dose Escalation: Enasidenib 300 mg QD
- description
- Participants received enasidenib 450 mg tablets QD on Day 1 to Day 28 of each 28-day treatment cycle until disease progression or development of unacceptable toxicity.
- id
- BG011
- title
- Phase 1 Dose Escalation: Enasidenib 450 mg QD
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 6.37
- value
- 62.6
- group Id
- BG001
- spread
- 8.86
- value
- 61.3
- group Id
- BG002
- spread
- 8.38
- value
- 64.7
- group Id
- BG003
- spread
- 12.88
- value
- 67.6
- group Id
- BG004
- spread
- 7.23
- value
- 73.6
- group Id
- BG005
- spread
- 9.00
- value
- 71.8
- group Id
- BG006
- spread
- 13.77
- value
- 62.3
- group Id
- BG007
- spread
- 15.06
- value
- 63.9
- group Id
- BG008
- spread
- 2.48
- value
- 73.8
- group Id
- BG009
- spread
- 14.69
- value
- 67.5
- group Id
- BG010
- spread
- 6.20
- value
- 68.3
- group Id
- BG011
- spread
- 8.77
- value
- 70.0
- denoms
- counts
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 8
- group Id
- BG004
- value
- 5
- group Id
- BG005
- value
- 9
- group Id
- BG006
- value
- 7
- group Id
- BG007
- value
- 22
- group Id
- BG008
- value
- 6
- group Id
- BG009
- value
- 14
- group Id
- BG010
- value
- 9
- group Id
- BG011
- value
- 5
- units
- Participants
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 2
- group Id
- BG006
- value
- 2
- group Id
- BG007
- value
- 10
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 6
- group Id
- BG010
- value
- 2
- group Id
- BG011
- value
- 1
- title
- < 65 Years Old
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 4
- group Id
- BG006
- value
- 5
- group Id
- BG007
- value
- 5
- group Id
- BG008
- value
- 4
- group Id
- BG009
- value
- 3
- group Id
- BG010
- value
- 5
- group Id
- BG011
- value
- 3
- title
- ≥ 65- < 75 Years Old
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 3
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 7
- group Id
- BG008
- value
- 2
- group Id
- BG009
- value
- 5
- group Id
- BG010
- value
- 2
- group Id
- BG011
- value
- 1
- title
- ≥ 75 Years Old
- denoms
- counts
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 8
- group Id
- BG004
- value
- 5
- group Id
- BG005
- value
- 9
- group Id
- BG006
- value
- 7
- group Id
- BG007
- value
- 22
- group Id
- BG008
- value
- 6
- group Id
- BG009
- value
- 14
- group Id
- BG010
- value
- 9
- group Id
- BG011
- value
- 5
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 4
- group Id
- BG004
- value
- 4
- group Id
- BG005
- value
- 4
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 11
- group Id
- BG008
- value
- 3
- group Id
- BG009
- value
- 3
- group Id
- BG010
- value
- 1
- group Id
- BG011
- value
- 1
- title
- Female
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 4
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 5
- group Id
- BG006
- value
- 7
- group Id
- BG007
- value
- 11
- group Id
- BG008
- value
- 3
- group Id
- BG009
- value
- 11
- group Id
- BG010
- value
- 8
- group Id
- BG011
- value
- 4
- title
- Male
- denoms
- counts
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 8
- group Id
- BG004
- value
- 5
- group Id
- BG005
- value
- 9
- group Id
- BG006
- value
- 7
- group Id
- BG007
- value
- 22
- group Id
- BG008
- value
- 6
- group Id
- BG009
- value
- 14
- group Id
- BG010
- value
- 9
- group Id
- BG011
- value
- 5
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 1
- group Id
- BG006
- value
- 1
- group Id
- BG007
- value
- 2
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- group Id
- BG010
- value
- 0
- group Id
- BG011
- value
- 0
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 5
- group Id
- BG003
- value
- 7
- group Id
- BG004
- value
- 3
- group Id
- BG005
- value
- 8
- group Id
- BG006
- value
- 3
- group Id
- BG007
- value
- 15
- group Id
- BG008
- value
- 6
- group Id
- BG009
- value
- 8
- group Id
- BG010
- value
- 8
- group Id
- BG011
- value
- 4
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 3
- group Id
- BG007
- value
- 5
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 6
- group Id
- BG010
- value
- 1
- group Id
- BG011
- value
- 1
- title
- Unknown or Not Reported
- denoms
- counts
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 8
- group Id
- BG004
- value
- 5
- group Id
- BG005
- value
- 9
- group Id
- BG006
- value
- 7
- group Id
- BG007
- value
- 22
- group Id
- BG008
- value
- 6
- group Id
- BG009
- value
- 14
- group Id
- BG010
- value
- 9
- group Id
- BG011
- value
- 5
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 6
- group Id
- BG003
- value
- 6
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 6
- group Id
- BG006
- value
- 5
- group Id
- BG007
- value
- 18
- group Id
- BG008
- value
- 6
- group Id
- BG009
- value
- 11
- group Id
- BG010
- value
- 8
- group Id
- BG011
- value
- 4
- title
- White
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 2
- group Id
- BG006
- value
- 1
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 1
- group Id
- BG010
- value
- 0
- group Id
- BG011
- value
- 0
- title
- Black
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 1
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- group Id
- BG010
- value
- 0
- group Id
- BG011
- value
- 0
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- group Id
- BG010
- value
- 0
- group Id
- BG011
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- group Id
- BG010
- value
- 0
- group Id
- BG011
- value
- 0
- title
- American Indian/Alaskan Native
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- group Id
- BG010
- value
- 0
- group Id
- BG011
- value
- 0
- title
- Other
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 3
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 1
- group Id
- BG007
- value
- 4
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 2
- group Id
- BG010
- value
- 1
- group Id
- BG011
- value
- 1
- title
- Not Provided
- denoms
- counts
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 8
- group Id
- BG004
- value
- 5
- group Id
- BG005
- value
- 9
- group Id
- BG006
- value
- 7
- group Id
- BG007
- value
- 22
- group Id
- BG008
- value
- 6
- group Id
- BG009
- value
- 14
- group Id
- BG010
- value
- 9
- group Id
- BG011
- value
- 5
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 4
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 2
- group Id
- BG007
- value
- 7
- group Id
- BG008
- value
- 1
- group Id
- BG009
- value
- 2
- group Id
- BG010
- value
- 2
- group Id
- BG011
- value
- 3
- title
- 0 - Fully active
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 5
- group Id
- BG003
- value
- 4
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 5
- group Id
- BG006
- value
- 4
- group Id
- BG007
- value
- 11
- group Id
- BG008
- value
- 4
- group Id
- BG009
- value
- 9
- group Id
- BG010
- value
- 4
- group Id
- BG011
- value
- 1
- title
- 1 - Restricted but ambulatory
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 4
- group Id
- BG006
- value
- 1
- group Id
- BG007
- value
- 4
- group Id
- BG008
- value
- 1
- group Id
- BG009
- value
- 3
- group Id
- BG010
- value
- 3
- group Id
- BG011
- value
- 1
- title
- 2 - Ambulatory but unable to work
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- group Id
- BG010
- value
- 0
- group Id
- BG011
- value
- 0
- title
- 3 - Limited self-care
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- group Id
- BG010
- value
- 0
- group Id
- BG011
- value
- 0
- title
- 4 - Completely Disabled
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- group Id
- BG010
- value
- 0
- group Id
- BG011
- value
- 0
- title
- Missing
- denoms
- counts
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 8
- group Id
- BG004
- value
- 5
- group Id
- BG005
- value
- 9
- group Id
- BG006
- value
- 7
- group Id
- BG007
- value
- 22
- group Id
- BG008
- value
- 6
- group Id
- BG009
- value
- 14
- group Id
- BG010
- value
- 9
- group Id
- BG011
- value
- 5
- units
- Participants
- description
- ECOG performance status is used to describe a patient's level of functioning in terms of their ability to care for themselves, daily activity, and physical ability (walking, working, etc.). The scale ranges from 0 to 5: -0 = Fully active, no restrictions; -1 = Restricted activity but ambulatory, able to carry out work of a light nature; -2 = Ambulatory and capable of all self-care but unable to carry out work activities; -3 = Limited self-care, confined to bed or chair more than 50% of waking hours; -4 = Completely disabled, no self-care, confined to bed or chair; -5 = Dead
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Eastern Cooperative Oncology Group (ECOG) Performance Status
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 6
- group Id
- BG003
- value
- 5
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 6
- group Id
- BG006
- value
- 6
- group Id
- BG007
- value
- 19
- group Id
- BG008
- value
- 5
- group Id
- BG009
- value
- 10
- group Id
- BG010
- value
- 9
- group Id
- BG011
- value
- 1
- title
- R140
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 3
- group Id
- BG006
- value
- 1
- group Id
- BG007
- value
- 3
- group Id
- BG008
- value
- 1
- group Id
- BG009
- value
- 4
- group Id
- BG010
- value
- 0
- group Id
- BG011
- value
- 4
- title
- R172
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- group Id
- BG010
- value
- 0
- group Id
- BG011
- value
- 0
- title
- Unknown
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- group Id
- BG010
- value
- 0
- group Id
- BG011
- value
- 0
- title
- Missing
- denoms
- counts
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 8
- group Id
- BG004
- value
- 5
- group Id
- BG005
- value
- 9
- group Id
- BG006
- value
- 7
- group Id
- BG007
- value
- 22
- group Id
- BG008
- value
- 6
- group Id
- BG009
- value
- 14
- group Id
- BG010
- value
- 9
- group Id
- BG011
- value
- 5
- units
- Participants
- description
- Isocitrate dehydrogenase 2 (IDH2) gene mutations have been described in patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). Mutations in IDH2 most commonly lead to alterations affecting arginine-172 (R172) or arginine-140 (R140) in IDH2.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Isocitrate dehydrogenase 2 (IDH2) Mutation Type
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 1
- group Id
- BG008
- value
- 2
- group Id
- BG009
- value
- 0
- group Id
- BG010
- value
- 0
- group Id
- BG011
- value
- 0
- title
- Heterozygous
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- group Id
- BG010
- value
- 1
- group Id
- BG011
- value
- 0
- title
- Homozygous
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- group Id
- BG010
- value
- 0
- group Id
- BG011
- value
- 0
- title
- Wild Type
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 7
- group Id
- BG004
- value
- 5
- group Id
- BG005
- value
- 9
- group Id
- BG006
- value
- 7
- group Id
- BG007
- value
- 21
- group Id
- BG008
- value
- 4
- group Id
- BG009
- value
- 14
- group Id
- BG010
- value
- 8
- group Id
- BG011
- value
- 5
- title
- Not Applicable
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- group Id
- BG010
- value
- 0
- group Id
- BG011
- value
- 0
- title
- Missing
- denoms
- counts
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 8
- group Id
- BG004
- value
- 5
- group Id
- BG005
- value
- 9
- group Id
- BG006
- value
- 7
- group Id
- BG007
- value
- 22
- group Id
- BG008
- value
- 6
- group Id
- BG009
- value
- 14
- group Id
- BG010
- value
- 9
- group Id
- BG011
- value
- 5
- units
- Participants
- description
- The UGT1A1 gene produces a protein, called the bilirubin uridine diphosphate glucuronosyl transferase (bilirubin-UGT) enzyme, an enzyme that glucuronidates bilirubin, a substance produced when red blood cells are broken down. This enzyme converts the toxic form of bilirubin (unconjugated bilirubin) to its nontoxic form (conjugated bilirubin), making it able to be dissolved and removed from the body. Enasidenib is an inhibitor of UGT1A1. Screening for UGT1A1 mutation was added in Protocol Amendment 4 therefore data are not not available for participants enrolled prior to Amendment 4.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Uridine Diphosphate-Glucuronosyltransferase 1 Family, Polypeptide A1 (UGT1A1) Mutation Status
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- group Id
- BG010
- value
- 0
- group Id
- BG011
- value
- 0
- title
- Favorable-Risk
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 5
- group Id
- BG006
- value
- 2
- group Id
- BG007
- value
- 6
- group Id
- BG008
- value
- 4
- group Id
- BG009
- value
- 9
- group Id
- BG010
- value
- 6
- group Id
- BG011
- value
- 3
- title
- Intermediate-Risk
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 3
- group Id
- BG006
- value
- 1
- group Id
- BG007
- value
- 8
- group Id
- BG008
- value
- 1
- group Id
- BG009
- value
- 2
- group Id
- BG010
- value
- 0
- group Id
- BG011
- value
- 1
- title
- Poor-Risk
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- group Id
- BG010
- value
- 0
- group Id
- BG011
- value
- 0
- title
- Failure
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 4
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 1
- group Id
- BG006
- value
- 4
- group Id
- BG007
- value
- 8
- group Id
- BG008
- value
- 1
- group Id
- BG009
- value
- 3
- group Id
- BG010
- value
- 3
- group Id
- BG011
- value
- 1
- title
- Missing
- denoms
- counts
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 8
- group Id
- BG004
- value
- 5
- group Id
- BG005
- value
- 9
- group Id
- BG006
- value
- 7
- group Id
- BG007
- value
- 22
- group Id
- BG008
- value
- 6
- group Id
- BG009
- value
- 14
- group Id
- BG010
- value
- 9
- group Id
- BG011
- value
- 5
- units
- Participants
- description
- Cytogenetic risk classification according to the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology for Acute Myeloid Leukemia. Risk categories are based on analysis of cytogenetics (the study of chromosomes), including chromosomal deletions, duplications, or substitutions and analysis of molecular abnormalities such as specific mutations. Better risk indicates disease more likely to respond to initial treatment and less likely to relapse whereas poor-risk is characterized by poor response to induction chemotherapy and higher relapse rates.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Cytogenetic Risk Status
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 2
- group Id
- BG007
- value
- 6
- group Id
- BG008
- value
- 2
- group Id
- BG009
- value
- 4
- group Id
- BG010
- value
- 3
- group Id
- BG011
- value
- 0
- title
- < 20% Blasts
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 1
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 1
- group Id
- BG009
- value
- 1
- group Id
- BG010
- value
- 1
- group Id
- BG011
- value
- 0
- title
- 20% to < 30% Blasts
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 2
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 5
- group Id
- BG008
- value
- 2
- group Id
- BG009
- value
- 5
- group Id
- BG010
- value
- 2
- group Id
- BG011
- value
- 2
- title
- 30% to < 50% Blasts
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 6
- group Id
- BG006
- value
- 4
- group Id
- BG007
- value
- 11
- group Id
- BG008
- value
- 1
- group Id
- BG009
- value
- 4
- group Id
- BG010
- value
- 3
- group Id
- BG011
- value
- 3
- title
- ≥ 50% Blasts
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 1
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- group Id
- BG010
- value
- 0
- group Id
- BG011
- value
- 0
- title
- Missing
- denoms
- counts
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 8
- group Id
- BG004
- value
- 5
- group Id
- BG005
- value
- 9
- group Id
- BG006
- value
- 7
- group Id
- BG007
- value
- 22
- group Id
- BG008
- value
- 6
- group Id
- BG009
- value
- 14
- group Id
- BG010
- value
- 9
- group Id
- BG011
- value
- 5
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Bone Marrow Blasts
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 6
- group Id
- BG003
- value
- 6
- group Id
- BG004
- value
- 3
- group Id
- BG005
- value
- 8
- group Id
- BG006
- value
- 5
- group Id
- BG007
- value
- 19
- group Id
- BG008
- value
- 3
- group Id
- BG009
- value
- 9
- group Id
- BG010
- value
- 8
- group Id
- BG011
- value
- 3
- title
- Relapsed / Refractory Acute Myeloid Leukemia (AML)
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 1
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 1
- group Id
- BG009
- value
- 3
- group Id
- BG010
- value
- 0
- group Id
- BG011
- value
- 2
- title
- Untreated AML
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 1
- group Id
- BG007
- value
- 3
- group Id
- BG008
- value
- 1
- group Id
- BG009
- value
- 1
- group Id
- BG010
- value
- 1
- group Id
- BG011
- value
- 0
- title
- Myelodysplastic Syndrome (MDS)
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 1
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 1
- group Id
- BG009
- value
- 1
- group Id
- BG010
- value
- 0
- group Id
- BG011
- value
- 0
- title
- Other
- denoms
- counts
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 8
- group Id
- BG004
- value
- 5
- group Id
- BG005
- value
- 9
- group Id
- BG006
- value
- 7
- group Id
- BG007
- value
- 22
- group Id
- BG008
- value
- 6
- group Id
- BG009
- value
- 14
- group Id
- BG010
- value
- 9
- group Id
- BG011
- value
- 5
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Malignancy Type
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 72.0
- upper Limit
- 95.0
- value
- 82.0
- group Id
- BG001
- lower Limit
- 82.0
- upper Limit
- 138.0
- value
- 97.0
- group Id
- BG002
- lower Limit
- 76.0
- upper Limit
- 111.0
- value
- 86.0
- group Id
- BG003
- lower Limit
- 75.0
- upper Limit
- 109.0
- value
- 97.5
- group Id
- BG004
- lower Limit
- 75.0
- upper Limit
- 93.0
- value
- 91.0
- group Id
- BG005
- lower Limit
- 77.0
- upper Limit
- 102.0
- value
- 89.0
- group Id
- BG006
- lower Limit
- 73.0
- upper Limit
- 110.0
- value
- 92.0
- group Id
- BG007
- lower Limit
- 78.0
- upper Limit
- 124.0
- value
- 96.5
- group Id
- BG008
- lower Limit
- 79.0
- upper Limit
- 132.0
- value
- 94.0
- group Id
- BG009
- lower Limit
- 76.0
- upper Limit
- 125.0
- value
- 87.5
- group Id
- BG010
- lower Limit
- 78.0
- upper Limit
- 131.0
- value
- 93.0
- group Id
- BG011
- lower Limit
- 70.0
- upper Limit
- 121.0
- value
- 103.0
- denoms
- counts
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 8
- group Id
- BG004
- value
- 5
- group Id
- BG005
- value
- 9
- group Id
- BG006
- value
- 7
- group Id
- BG007
- value
- 22
- group Id
- BG008
- value
- 6
- group Id
- BG009
- value
- 14
- group Id
- BG010
- value
- 9
- group Id
- BG011
- value
- 5
- units
- Participants
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- population Description
- Participants with available data.
- title
- Hemoglobin
- unit Of Measure
- g/L
- population Description
- The full analysis set includes all participants who received at least one dose of study treatment.
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 8
- group Id
- BG004
- value
- 5
- group Id
- BG005
- value
- 9
- group Id
- BG006
- value
- 7
- group Id
- BG007
- value
- 22
- group Id
- BG008
- value
- 6
- group Id
- BG009
- value
- 14
- group Id
- BG010
- value
- 9
- group Id
- BG011
- value
- 5
- units
- Participants
- groups
- description
- Participants received enasidenib 30 mg tablets twice a day (BID) on Day 1 to Day 28 of each 28-day treatment cycle until disease progression or development of unacceptable toxicity.
- id
- BG000
- title
- Phase 1 Dose Escalation: Enasidenib 30 mg BID
- description
- Participants received enasidenib 50 mg tablets BID on Day 1 to Day 28 of each 28-day treatment cycle until disease progression or development of unacceptable toxicity.
- id
- BG001
- title
- Phase 1 Dose Escalation: Enasidenib 50 mg BID
- description
- Participants received enasidenib 75 mg tablets BID on Day 1 to Day 28 of each 28-day treatment cycle until disease progression or development of unacceptable toxicity.
- id
- BG002
- title
- Phase 1 Dose Escalation: Enasidenib 75 mg BID
- description
- Participants received enasidenib 100 mg tablets BID on Day 1 to Day 28 of each 28-day treatment cycle until disease progression or development of unacceptable toxicity.
- id
- BG003
- title
- Phase 1 Dose Escalation: Enasidenib 100 mg BID
- description
- Participants received enasidenib 150 mg tablets BID on Day 1 to Day 28 of each 28-day treatment cycle until disease progression or development of unacceptable toxicity.
- id
- BG004
- title
- Phase 1 Dose Escalation: Enasidenib 150 mg BID
- description
- Participants received enasidenib 50 mg tablets once a day (QD) on Day 1 to Day 28 of each 28-day treatment cycle until disease progression or development of unacceptable toxicity.
- id
- BG005
- title
- Phase 1 Dose Escalation: Enasidenib 50 mg QD
- description
- Participants received enasidenib 75 mg tablets QD on Day 1 to Day 28 of each 28-day treatment cycle until disease progression or development of unacceptable toxicity.
- id
- BG006
- title
- Phase 1 Dose Escalation: Enasidenib 75 mg QD
- description
- Participants received enasidenib 100 mg tablets QD on Day 1 to Day 28 of each 28-day treatment cycle until disease progression or development of unacceptable toxicity.
- id
- BG007
- title
- Phase 1 Dose Escalation: Enasidenib 100 mg QD
- description
- Participants received enasidenib 150 mg tablets QD on Day 1 to Day 28 of each 28-day treatment cycle until disease progression or development of unacceptable toxicity.
- id
- BG008
- title
- Phase 1 Dose Escalation: Enasidenib 150 mg QD
- description
- Participants received enasidenib 200 mg tablets QD on Day 1 to Day 28 of each 28-day treatment cycle until disease progression or development of unacceptable toxicity.
- id
- BG009
- title
- Phase 1 Dose Escalation: Enasidenib 200 mg QD
- description
- Participants received enasidenib 300 mg tablets QD on Day 1 to Day 28 of each 28-day treatment cycle until disease progression or development of unacceptable toxicity.
- id
- BG010
- title
- Phase 1 Dose Escalation: Enasidenib 300 mg QD
- description
- Participants received enasidenib 450 mg tablets QD on Day 1 to Day 28 of each 28-day treatment cycle until disease progression or development of unacceptable toxicity.
- id
- BG011
- title
- Phase 1 Dose Escalation: Enasidenib 450 mg QD
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 6.37
- value
- 62.6
- group Id
- BG001
- spread
- 8.86
- value
- 61.3
- group Id
- BG002
- spread
- 8.38
- value
- 64.7
- group Id
- BG003
- spread
- 12.88
- value
- 67.6
- group Id
- BG004
- spread
- 7.23
- value
- 73.6
- group Id
- BG005
- spread
- 9.00
- value
- 71.8
- group Id
- BG006
- spread
- 13.77
- value
- 62.3
- group Id
- BG007
- spread
- 15.06
- value
- 63.9
- group Id
- BG008
- spread
- 2.48
- value
- 73.8
- group Id
- BG009
- spread
- 14.69
- value
- 67.5
- group Id
- BG010
- spread
- 6.20
- value
- 68.3
- group Id
- BG011
- spread
- 8.77
- value
- 70.0
- denoms
- counts
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 8
- group Id
- BG004
- value
- 5
- group Id
- BG005
- value
- 9
- group Id
- BG006
- value
- 7
- group Id
- BG007
- value
- 22
- group Id
- BG008
- value
- 6
- group Id
- BG009
- value
- 14
- group Id
- BG010
- value
- 9
- group Id
- BG011
- value
- 5
- units
- Participants
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 2
- group Id
- BG006
- value
- 2
- group Id
- BG007
- value
- 10
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 6
- group Id
- BG010
- value
- 2
- group Id
- BG011
- value
- 1
- title
- < 65 Years Old
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 4
- group Id
- BG006
- value
- 5
- group Id
- BG007
- value
- 5
- group Id
- BG008
- value
- 4
- group Id
- BG009
- value
- 3
- group Id
- BG010
- value
- 5
- group Id
- BG011
- value
- 3
- title
- ≥ 65- < 75 Years Old
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 3
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 7
- group Id
- BG008
- value
- 2
- group Id
- BG009
- value
- 5
- group Id
- BG010
- value
- 2
- group Id
- BG011
- value
- 1
- title
- ≥ 75 Years Old
- denoms
- counts
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 8
- group Id
- BG004
- value
- 5
- group Id
- BG005
- value
- 9
- group Id
- BG006
- value
- 7
- group Id
- BG007
- value
- 22
- group Id
- BG008
- value
- 6
- group Id
- BG009
- value
- 14
- group Id
- BG010
- value
- 9
- group Id
- BG011
- value
- 5
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 4
- group Id
- BG004
- value
- 4
- group Id
- BG005
- value
- 4
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 11
- group Id
- BG008
- value
- 3
- group Id
- BG009
- value
- 3
- group Id
- BG010
- value
- 1
- group Id
- BG011
- value
- 1
- title
- Female
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 4
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 5
- group Id
- BG006
- value
- 7
- group Id
- BG007
- value
- 11
- group Id
- BG008
- value
- 3
- group Id
- BG009
- value
- 11
- group Id
- BG010
- value
- 8
- group Id
- BG011
- value
- 4
- title
- Male
- denoms
- counts
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 8
- group Id
- BG004
- value
- 5
- group Id
- BG005
- value
- 9
- group Id
- BG006
- value
- 7
- group Id
- BG007
- value
- 22
- group Id
- BG008
- value
- 6
- group Id
- BG009
- value
- 14
- group Id
- BG010
- value
- 9
- group Id
- BG011
- value
- 5
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 1
- group Id
- BG006
- value
- 1
- group Id
- BG007
- value
- 2
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- group Id
- BG010
- value
- 0
- group Id
- BG011
- value
- 0
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 5
- group Id
- BG003
- value
- 7
- group Id
- BG004
- value
- 3
- group Id
- BG005
- value
- 8
- group Id
- BG006
- value
- 3
- group Id
- BG007
- value
- 15
- group Id
- BG008
- value
- 6
- group Id
- BG009
- value
- 8
- group Id
- BG010
- value
- 8
- group Id
- BG011
- value
- 4
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 3
- group Id
- BG007
- value
- 5
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 6
- group Id
- BG010
- value
- 1
- group Id
- BG011
- value
- 1
- title
- Unknown or Not Reported
- denoms
- counts
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 8
- group Id
- BG004
- value
- 5
- group Id
- BG005
- value
- 9
- group Id
- BG006
- value
- 7
- group Id
- BG007
- value
- 22
- group Id
- BG008
- value
- 6
- group Id
- BG009
- value
- 14
- group Id
- BG010
- value
- 9
- group Id
- BG011
- value
- 5
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 6
- group Id
- BG003
- value
- 6
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 6
- group Id
- BG006
- value
- 5
- group Id
- BG007
- value
- 18
- group Id
- BG008
- value
- 6
- group Id
- BG009
- value
- 11
- group Id
- BG010
- value
- 8
- group Id
- BG011
- value
- 4
- title
- White
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 2
- group Id
- BG006
- value
- 1
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 1
- group Id
- BG010
- value
- 0
- group Id
- BG011
- value
- 0
- title
- Black
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 1
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- group Id
- BG010
- value
- 0
- group Id
- BG011
- value
- 0
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- group Id
- BG010
- value
- 0
- group Id
- BG011
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- group Id
- BG010
- value
- 0
- group Id
- BG011
- value
- 0
- title
- American Indian/Alaskan Native
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- group Id
- BG010
- value
- 0
- group Id
- BG011
- value
- 0
- title
- Other
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 3
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 1
- group Id
- BG007
- value
- 4
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 2
- group Id
- BG010
- value
- 1
- group Id
- BG011
- value
- 1
- title
- Not Provided
- denoms
- counts
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 8
- group Id
- BG004
- value
- 5
- group Id
- BG005
- value
- 9
- group Id
- BG006
- value
- 7
- group Id
- BG007
- value
- 22
- group Id
- BG008
- value
- 6
- group Id
- BG009
- value
- 14
- group Id
- BG010
- value
- 9
- group Id
- BG011
- value
- 5
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 4
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 2
- group Id
- BG007
- value
- 7
- group Id
- BG008
- value
- 1
- group Id
- BG009
- value
- 2
- group Id
- BG010
- value
- 2
- group Id
- BG011
- value
- 3
- title
- 0 - Fully active
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 5
- group Id
- BG003
- value
- 4
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 5
- group Id
- BG006
- value
- 4
- group Id
- BG007
- value
- 11
- group Id
- BG008
- value
- 4
- group Id
- BG009
- value
- 9
- group Id
- BG010
- value
- 4
- group Id
- BG011
- value
- 1
- title
- 1 - Restricted but ambulatory
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 4
- group Id
- BG006
- value
- 1
- group Id
- BG007
- value
- 4
- group Id
- BG008
- value
- 1
- group Id
- BG009
- value
- 3
- group Id
- BG010
- value
- 3
- group Id
- BG011
- value
- 1
- title
- 2 - Ambulatory but unable to work
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- group Id
- BG010
- value
- 0
- group Id
- BG011
- value
- 0
- title
- 3 - Limited self-care
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- group Id
- BG010
- value
- 0
- group Id
- BG011
- value
- 0
- title
- 4 - Completely Disabled
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- group Id
- BG010
- value
- 0
- group Id
- BG011
- value
- 0
- title
- Missing
- denoms
- counts
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 8
- group Id
- BG004
- value
- 5
- group Id
- BG005
- value
- 9
- group Id
- BG006
- value
- 7
- group Id
- BG007
- value
- 22
- group Id
- BG008
- value
- 6
- group Id
- BG009
- value
- 14
- group Id
- BG010
- value
- 9
- group Id
- BG011
- value
- 5
- units
- Participants
- description
- ECOG performance status is used to describe a patient's level of functioning in terms of their ability to care for themselves, daily activity, and physical ability (walking, working, etc.). The scale ranges from 0 to 5: -0 = Fully active, no restrictions; -1 = Restricted activity but ambulatory, able to carry out work of a light nature; -2 = Ambulatory and capable of all self-care but unable to carry out work activities; -3 = Limited self-care, confined to bed or chair more than 50% of waking hours; -4 = Completely disabled, no self-care, confined to bed or chair; -5 = Dead
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Eastern Cooperative Oncology Group (ECOG) Performance Status
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 6
- group Id
- BG003
- value
- 5
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 6
- group Id
- BG006
- value
- 6
- group Id
- BG007
- value
- 19
- group Id
- BG008
- value
- 5
- group Id
- BG009
- value
- 10
- group Id
- BG010
- value
- 9
- group Id
- BG011
- value
- 1
- title
- R140
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 3
- group Id
- BG006
- value
- 1
- group Id
- BG007
- value
- 3
- group Id
- BG008
- value
- 1
- group Id
- BG009
- value
- 4
- group Id
- BG010
- value
- 0
- group Id
- BG011
- value
- 4
- title
- R172
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- group Id
- BG010
- value
- 0
- group Id
- BG011
- value
- 0
- title
- Unknown
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- group Id
- BG010
- value
- 0
- group Id
- BG011
- value
- 0
- title
- Missing
- denoms
- counts
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 8
- group Id
- BG004
- value
- 5
- group Id
- BG005
- value
- 9
- group Id
- BG006
- value
- 7
- group Id
- BG007
- value
- 22
- group Id
- BG008
- value
- 6
- group Id
- BG009
- value
- 14
- group Id
- BG010
- value
- 9
- group Id
- BG011
- value
- 5
- units
- Participants
- description
- Isocitrate dehydrogenase 2 (IDH2) gene mutations have been described in patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). Mutations in IDH2 most commonly lead to alterations affecting arginine-172 (R172) or arginine-140 (R140) in IDH2.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Isocitrate dehydrogenase 2 (IDH2) Mutation Type
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 1
- group Id
- BG008
- value
- 2
- group Id
- BG009
- value
- 0
- group Id
- BG010
- value
- 0
- group Id
- BG011
- value
- 0
- title
- Heterozygous
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- group Id
- BG010
- value
- 1
- group Id
- BG011
- value
- 0
- title
- Homozygous
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- group Id
- BG010
- value
- 0
- group Id
- BG011
- value
- 0
- title
- Wild Type
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 7
- group Id
- BG004
- value
- 5
- group Id
- BG005
- value
- 9
- group Id
- BG006
- value
- 7
- group Id
- BG007
- value
- 21
- group Id
- BG008
- value
- 4
- group Id
- BG009
- value
- 14
- group Id
- BG010
- value
- 8
- group Id
- BG011
- value
- 5
- title
- Not Applicable
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- group Id
- BG010
- value
- 0
- group Id
- BG011
- value
- 0
- title
- Missing
- denoms
- counts
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 8
- group Id
- BG004
- value
- 5
- group Id
- BG005
- value
- 9
- group Id
- BG006
- value
- 7
- group Id
- BG007
- value
- 22
- group Id
- BG008
- value
- 6
- group Id
- BG009
- value
- 14
- group Id
- BG010
- value
- 9
- group Id
- BG011
- value
- 5
- units
- Participants
- description
- The UGT1A1 gene produces a protein, called the bilirubin uridine diphosphate glucuronosyl transferase (bilirubin-UGT) enzyme, an enzyme that glucuronidates bilirubin, a substance produced when red blood cells are broken down. This enzyme converts the toxic form of bilirubin (unconjugated bilirubin) to its nontoxic form (conjugated bilirubin), making it able to be dissolved and removed from the body. Enasidenib is an inhibitor of UGT1A1. Screening for UGT1A1 mutation was added in Protocol Amendment 4 therefore data are not not available for participants enrolled prior to Amendment 4.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Uridine Diphosphate-Glucuronosyltransferase 1 Family, Polypeptide A1 (UGT1A1) Mutation Status
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- group Id
- BG010
- value
- 0
- group Id
- BG011
- value
- 0
- title
- Favorable-Risk
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 5
- group Id
- BG006
- value
- 2
- group Id
- BG007
- value
- 6
- group Id
- BG008
- value
- 4
- group Id
- BG009
- value
- 9
- group Id
- BG010
- value
- 6
- group Id
- BG011
- value
- 3
- title
- Intermediate-Risk
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 3
- group Id
- BG006
- value
- 1
- group Id
- BG007
- value
- 8
- group Id
- BG008
- value
- 1
- group Id
- BG009
- value
- 2
- group Id
- BG010
- value
- 0
- group Id
- BG011
- value
- 1
- title
- Poor-Risk
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- group Id
- BG010
- value
- 0
- group Id
- BG011
- value
- 0
- title
- Failure
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 4
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 1
- group Id
- BG006
- value
- 4
- group Id
- BG007
- value
- 8
- group Id
- BG008
- value
- 1
- group Id
- BG009
- value
- 3
- group Id
- BG010
- value
- 3
- group Id
- BG011
- value
- 1
- title
- Missing
- denoms
- counts
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 8
- group Id
- BG004
- value
- 5
- group Id
- BG005
- value
- 9
- group Id
- BG006
- value
- 7
- group Id
- BG007
- value
- 22
- group Id
- BG008
- value
- 6
- group Id
- BG009
- value
- 14
- group Id
- BG010
- value
- 9
- group Id
- BG011
- value
- 5
- units
- Participants
- description
- Cytogenetic risk classification according to the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology for Acute Myeloid Leukemia. Risk categories are based on analysis of cytogenetics (the study of chromosomes), including chromosomal deletions, duplications, or substitutions and analysis of molecular abnormalities such as specific mutations. Better risk indicates disease more likely to respond to initial treatment and less likely to relapse whereas poor-risk is characterized by poor response to induction chemotherapy and higher relapse rates.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Cytogenetic Risk Status
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 2
- group Id
- BG007
- value
- 6
- group Id
- BG008
- value
- 2
- group Id
- BG009
- value
- 4
- group Id
- BG010
- value
- 3
- group Id
- BG011
- value
- 0
- title
- < 20% Blasts
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 1
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 1
- group Id
- BG009
- value
- 1
- group Id
- BG010
- value
- 1
- group Id
- BG011
- value
- 0
- title
- 20% to < 30% Blasts
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 1
- group Id
- BG005
- value
- 2
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 5
- group Id
- BG008
- value
- 2
- group Id
- BG009
- value
- 5
- group Id
- BG010
- value
- 2
- group Id
- BG011
- value
- 2
- title
- 30% to < 50% Blasts
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 6
- group Id
- BG006
- value
- 4
- group Id
- BG007
- value
- 11
- group Id
- BG008
- value
- 1
- group Id
- BG009
- value
- 4
- group Id
- BG010
- value
- 3
- group Id
- BG011
- value
- 3
- title
- ≥ 50% Blasts
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 1
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 0
- group Id
- BG009
- value
- 0
- group Id
- BG010
- value
- 0
- group Id
- BG011
- value
- 0
- title
- Missing
- denoms
- counts
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 8
- group Id
- BG004
- value
- 5
- group Id
- BG005
- value
- 9
- group Id
- BG006
- value
- 7
- group Id
- BG007
- value
- 22
- group Id
- BG008
- value
- 6
- group Id
- BG009
- value
- 14
- group Id
- BG010
- value
- 9
- group Id
- BG011
- value
- 5
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Bone Marrow Blasts
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 6
- group Id
- BG003
- value
- 6
- group Id
- BG004
- value
- 3
- group Id
- BG005
- value
- 8
- group Id
- BG006
- value
- 5
- group Id
- BG007
- value
- 19
- group Id
- BG008
- value
- 3
- group Id
- BG009
- value
- 9
- group Id
- BG010
- value
- 8
- group Id
- BG011
- value
- 3
- title
- Relapsed / Refractory Acute Myeloid Leukemia (AML)
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 2
- group Id
- BG005
- value
- 1
- group Id
- BG006
- value
- 0
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 1
- group Id
- BG009
- value
- 3
- group Id
- BG010
- value
- 0
- group Id
- BG011
- value
- 2
- title
- Untreated AML
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 1
- group Id
- BG007
- value
- 3
- group Id
- BG008
- value
- 1
- group Id
- BG009
- value
- 1
- group Id
- BG010
- value
- 1
- group Id
- BG011
- value
- 0
- title
- Myelodysplastic Syndrome (MDS)
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- group Id
- BG005
- value
- 0
- group Id
- BG006
- value
- 1
- group Id
- BG007
- value
- 0
- group Id
- BG008
- value
- 1
- group Id
- BG009
- value
- 1
- group Id
- BG010
- value
- 0
- group Id
- BG011
- value
- 0
- title
- Other
- denoms
- counts
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 8
- group Id
- BG004
- value
- 5
- group Id
- BG005
- value
- 9
- group Id
- BG006
- value
- 7
- group Id
- BG007
- value
- 22
- group Id
- BG008
- value
- 6
- group Id
- BG009
- value
- 14
- group Id
- BG010
- value
- 9
- group Id
- BG011
- value
- 5
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Malignancy Type
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 72.0
- upper Limit
- 95.0
- value
- 82.0
- group Id
- BG001
- lower Limit
- 82.0
- upper Limit
- 138.0
- value
- 97.0
- group Id
- BG002
- lower Limit
- 76.0
- upper Limit
- 111.0
- value
- 86.0
- group Id
- BG003
- lower Limit
- 75.0
- upper Limit
- 109.0
- value
- 97.5
- group Id
- BG004
- lower Limit
- 75.0
- upper Limit
- 93.0
- value
- 91.0
- group Id
- BG005
- lower Limit
- 77.0
- upper Limit
- 102.0
- value
- 89.0
- group Id
- BG006
- lower Limit
- 73.0
- upper Limit
- 110.0
- value
- 92.0
- group Id
- BG007
- lower Limit
- 78.0
- upper Limit
- 124.0
- value
- 96.5
- group Id
- BG008
- lower Limit
- 79.0
- upper Limit
- 132.0
- value
- 94.0
- group Id
- BG009
- lower Limit
- 76.0
- upper Limit
- 125.0
- value
- 87.5
- group Id
- BG010
- lower Limit
- 78.0
- upper Limit
- 131.0
- value
- 93.0
- group Id
- BG011
- lower Limit
- 70.0
- upper Limit
- 121.0
- value
- 103.0
- denoms
- counts
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 8
- group Id
- BG004
- value
- 5
- group Id
- BG005
- value
- 9
- group Id
- BG006
- value
- 7
- group Id
- BG007
- value
- 22
- group Id
- BG008
- value
- 6
- group Id
- BG009
- value
- 14
- group Id
- BG010
- value
- 9
- group Id
- BG011
- value
- 5
- units
- Participants
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- population Description
- Participants with available data.
- title
- Hemoglobin
- unit Of Measure
- g/L
- population Description
- The full analysis set includes all participants who received at least one dose of study treatment.
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle